Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

Share Price is delayed by 15 minutes
Get Live Data
4,890.00    130.00 (2.73%)
Bid:
4,894.00
Ask:
4,898.00
Spread: 4.00 (0.082%)
Market Cap: £17.82b
CCH Live PriceLast checked at - London Stock Exchange

Intraday Coca-Cola HBC Share Chart

Result of AGM

16 Jun 2020 13:06

RNS Number : 1359Q
Coca-Cola HBC AG
16 June 2020
Β 

Β 

FOR IMMEDIATE RELEASE

Coca-Cola HBC AG

Results of Annual General Meeting of Coca-Cola HBC AG and election of Ms. Anna Diamantopoulou as a new Member of the Board of Directors

Β 

Β 

Zug, Switzerland - 16 June 2020 - Coca-Cola HBC AG ("Coca-Cola HBC") today announces that all of the proposals of the Board of Directors (the "Board") set out in the notice of the annual general meeting ("AGM") dated 14 May 2020 were duly passed by the requisite majority of shareholders at its AGM held today, 16 June 2020. The final results are set out below. A copy of the resolutions passed at the AGM has also been submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanismΒ and on Coca-Cola HBC's website at www.coca-colahellenic.com

Β 

Coca-Cola HBC's shareholders elected Ms. Anna Diamantopoulou as a new member of the Board. Her biography can be found at www.coca-colahellenic.com

Β 

The AGM approved a dividend of EUR 0.62 per share ("Dividend") out of the general capital contribution reserve, capped at an amount of CHF 300,000,000. Payment of the full amount of the Dividend will be made on 28 July 2020 to holders of ordinary shares on the record date of 3 July 2020. The shares are expected to be traded ex-dividend as of 2 July 2020, in which case the last day on which the shares may be traded with the entitlement to receive dividends will be 1 July 2020. In addition, the AGM approved a share buy back of up to up to 10,000,000 ordinary shares of CHF 6.70.

Β 

Final Ballot Results

Β 

Proposal

Votes

for

%

(1)

Votes Against

%

(1)

Abs-

tentions Cast

%

(1)

Total Votes Cast

Votes not cast (2)

Voting Rights Repre-

sented % (3)

1.

Receipt of the 2019 Integrated Annual Report, as well as approval of the annual management report, the stand-alone financial statements and the consolidated financial statements

268113726

99.91%

9374

0.01%

207013

0.08%

268330113

0

73.70%

2.1.

Appropriation of available earnings

267914411

99.84%

342319

0.13%

73383

0.03%

268330113

0

73.70%

2.2.

Declaration of dividends from reserves

267869664

99.83%

342419

0.13%

118030

0.04%

268330113

0

73.70%

3.

Discharge of the members of the Board of Directors and the members of the Operating Committee

267291138

99.61%

773201

0.29%

265774

0.10%

268330113

0

73.70%

4.1.1.

Re-election of Anastassis G. David as a member of the Board of Directors and as the Chairman of the Board of Directors

253318388

94.41%

13100559

4.88%

1911166

0.71%

268330113

0

73.70%

Β 

Β 

4.1.2.

Re-election of Zoran Bogdanovic as a member of the Board of Directors

265654637

99.00%

2600593

0.97%

74883

0.03%

268330113

0

73.70%

4.1.3.

Re-election of Charlotte J. Boyle as a member of the Board of Directors and as a member of the Remuneration Committee

266641168

99.37%

1613126

0.60%

75819

0.03%

268330113

0

73.70%

4.1.4.

Re-election of Reto Francioni as a member of the Board of Directors and as a member of the Remuneration Committee

261089665

97.30%

7164629

2.67%

75819

0.03%

268330113

0

73.70%

4.1.5.

Re-election of Olusola David-Borha as a member of the Board of Directors

267615601

99.73%

639629

0.24%

74883

0.03%

268330113

0

73.70%

4.1.6.

Re-election of William W. Douglas III as a member of the Board of Directors

264913584

98.72%

3340710

1.25%

75819

0.03%

268330113

0

73.70%

4.1.7.

Re-election of Anastasios I. Leventis as a member of the Board of Directors

260883393

97.22%

7373337

2.75%

73383

0.03%

268330113

0

73.70%

4.1.8.

Re-election of Christodoulos Leventis as a member of the Board of Directors

260931101

97.24%

7325629

2.73%

73383

0.03%

268330113

0

73.70%

4.1.9.

Re-election of Alexandra Papalexopoulou as a member of the Board of Directors

266221934

99.21%

2034796

0.76%

73383

0.03%

268330113

0

73.70%

4.1.10.

Re-election of JosΓ© Octavio Reyes as a member of the Board of Directors

260928288

97.24%

7186935

2.68%

214890

0.08%

268330113

0

73.70%

4.1.11.

Re-election of Alfredo Rivera as a member of the Board of Directors

259175697

96.59%

8934059

3.33%

220357

0.08%

268330113

0

73.70%

4.1.12.

Re-election of Ryan Rudolph as a member of the Board of Directors

260754467

97.17%

7499827

2.80%

75819

0.03%

268330113

0

73.70%

4.2.

Election of Anna Diamantopoulou as a new member of the Board of Directors and as a new member of the Remuneration Committee

267859645

99.82%

394439

0.15%

76029

0.03%

268330113

0

73.70%

5.

Election of the independent proxy

266385199

99.27%

1870331

0.70%

74583

0.03%

268330113

0

73.70%

6.1.

Re-election of the statutory auditor

264612676

98.62%

3597857

1.34%

119580

0.04%

268330113

0

73.70%

6.2.

Advisory vote on re-appointment of the independent registered public accounting firm for UK purposes

266544842

99.33%

1708237

0.64%

77034

0.03%

268330113

0

73.70%

7.

Advisory vote on the UK Remuneration Report

261130154

97.32%

5744287

2.14%

1455672

0.54%

268330113

0

73.70%

8.

Advisory vote on the Remuneration Policy

251002866

93.54%

17250378

6.43%

76869

0.03%

268330113

0

73.70%

9.

Advisory vote on the Swiss Remuneration Report

261453104

97.44%

6799039

2.53%

77970

0.03%

268330113

0

73.70%

10.1.

Approval of the maximum aggregate amount of remuneration for the Board of Directors until the next annual general meeting

267895965

99.87%

347298

0.13%

86850

n.a.

268243263

0

73.70%

10.2.

Approval of the maximum aggregate amount of remuneration for the Operating Committee for the next financial year

265205431

99.38%

1660130

0.62%

1464552

n.a.

266865561

0

73.70%

11.

Approval of share buy-back

265309621

98.88%

2933228

1.09%

87264

0.03%

268330113

0

73.70%

Β 

(1) Percentages refer to applicable majority. Proposals 1-9 require approval by an absolute majority of the votes validly cast (including consenting and dissenting votes and abstentions). Proposals 10.1 and 10.2 require approval by a relative majority of the votes validly cast (including consenting and dissenting votes without abstentions). Proposal 11 requires approval by an absolute majority of the votes validly cast (including consenting and dissenting votes and abstentions).

Β 

(2) Votes represented at the AGM but not (or not validly) cast.

Β 

(3) Shares represented at the AGM for each proposal as a percentage of Coca-Cola HBC's outstanding voting rights, whether exercisable or not. As at the date of the AGM, Coca-Cola HBC's issued share capital consisted of 370'251'684 ordinary shares, of which 2'759'280 ordinary shares are held by Coca-Cola HBC AG and 3'430'135 shares are held by its subsidiary, COCA-COLA HBC SERVICES MEPE, in treasury. Accordingly, the total number of outstanding voting rights (whether exercisable or not) in Coca-Cola HBC AG was 364'062'269.

Β 

Β 

Β 

Enquiries

Coca‑Cola HBC Group

Investors and Analysts:

Β 

Joanna Kennedy

Investor Relations Director

Tel: +44 20 37 444 230

Β joanna.kennedy@cchellenic.com

Β 

Β 

Carla Fabiano

Investor Relations Manager

Tel: +44 20 37 444 231

carla.fabiano@cchellenic.com

Β 

Β 

Β 

Β 

Media:

Β 

Β 

David Hart

Group Communication Director

Tel: +41 41 726 0143

Β david.hart@cchellenic.com

Β 

Β 

Β 

International media contact:

Teneo

Rob Morgan

Tom Davies

Tel: +44 7557 413 275

robert.morgan@teneo.com

tom.davies@teneo.com

Β 

Β 

Greek media contact:

V+O Communications

Argyro Oikonomou

Tel: +30 211 7501219

ao@vando.gr

Β 

Β 

Β 

Β Β Β Β Β Β 

Β 

About Coca‑Cola HBC

Coca-Cola HBC is a leading bottler of The Coca-Cola Company with 2019 revenue in excess of €7 billion. It has a broad geographic footprint with operations in 28 countries serving a population of more than 600 million people. Coca-Cola HBC offers a diverse range of primarily non-alcoholic ready-to-drink beverages in the sparkling, juice, water, sport, energy, plant based beverages and ready-to-drink tea and coffee categories. Coca-Cola HBC is committed to promoting sustainable development in order to create value for its business and for society. This includes providing products that meet the beverage needs of consumers, fostering an open and inclusive work environment, conducting its business in ways that protect and preserve the environment and contribute to the socio-economic development of the local communities. Coca-Cola HBC is ranked among the top sustainability performers in ESG benchmarks such as the Dow Jones Sustainability Indices, CDP, MSCI ESG and FTSE4Good, among others.

Coca-Cola HBC has a premium listing on the London Stock Exchange (LSE: CCH) and its shares are listed on the Athens Exchange (ATHEX: EEE). For more information, please visit http://www.coca-colahellenic.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
RAGEAAKKFEAEEFA
Date   Source Headline
26th Jun 20269:15 amRNSDirector/PDMR Shareholding
26th Jun 20269:15 amRNSDirector/PDMR Shareholding
18th Jun 20263:15 pmRNSDirector/PDMR Shareholding
15th Jun 20265:00 pmRNSDirector/PDMR Shareholding
22nd May 20263:30 pmRNSDirector/PDMR Shareholding
19th May 20263:15 pmRNSDirector/PDMR Shareholding
11th May 20269:00 amRNSDirector Declaration
8th May 20263:15 pmRNSComposition of the Board Committees
8th May 20263:10 pmRNSResult of AGM
7th May 20267:00 amRNSStrong volume drives Q1 sales growth
20th Apr 20263:15 pmRNSDirector/PDMR Shareholding
14th Apr 202612:15 pmRNSNotice of Results
2nd Apr 20267:00 amRNSNotice of AGM, changes to the BoD, dividend dates
1st Apr 20269:15 amRNSTransfer of treasury shares & total voting rights
31st Mar 202611:00 amRNSPublication of Final Terms
27th Mar 20262:45 pmRNSDirector/PDMR Shareholding
27th Mar 20262:15 pmRNSDirector/PDMR Shareholding
26th Mar 20266:18 pmRNSPricing of Issue of Notes
26th Mar 20269:05 amRNSLaunch of Issue of Notes
25th Mar 20261:36 pmRNSPublication of a Prospectus
20th Mar 202611:00 amRNSAnnual Financial Report
19th Mar 20264:55 pmRNSDirector/PDMR Shareholding
19th Mar 20264:45 pmRNSDirector/PDMR Shareholding
18th Mar 20264:15 pmRNSDirector/PDMR Shareholding
18th Mar 202611:35 amRNSDirector/PDMR Shareholding
26th Feb 202611:30 amRNSDirector/PDMR Shareholding
25th Feb 20269:20 amRNSDirector/PDMR Shareholding
24th Feb 20264:55 pmRNSDirector/PDMR Shareholding
24th Feb 20264:50 pmRNSDirector/PDMR Shareholding
23rd Feb 20264:40 pmRNSDirector/PDMR Shareholding
23rd Feb 20264:35 pmRNSDirector/PDMR Shareholding
18th Feb 20264:50 pmRNSDirector/PDMR Shareholding
18th Feb 20264:45 pmRNSDirector/PDMR Shareholding
18th Feb 20264:00 pmRNSDirector/PDMR Shareholding
17th Feb 20263:35 pmRNSDirector/PDMR Shareholding
17th Feb 20263:30 pmRNSDirector/PDMR Shareholding
16th Feb 20262:40 pmRNSDirector/PDMR Shareholding
16th Feb 20262:35 pmRNSDirector/PDMR Shareholding
13th Feb 202610:30 amRNSDirector/PDMR Shareholding
12th Feb 20263:45 pmRNSDirector/PDMR Shareholding
12th Feb 20261:15 pmRNSDirector/PDMR Shareholding
10th Feb 20267:00 amRNSStrong execution and financial performance in 2025
2nd Feb 202610:00 amRNSTransfer of treasury shares & total voting rights
19th Jan 20264:00 pmRNSDirector/PDMR Shareholding
19th Jan 20262:20 pmRNSResult of Extraordinary General Meeting
13th Jan 202611:00 amRNSNotice of Results
5th Jan 202610:00 amRNSDirector/PDMR Shareholding
23rd Dec 20252:45 pmRNSDirector/PDMR Shareholding
23rd Dec 20252:45 pmRNSDirector/PDMR Shareholding
22nd Dec 20252:15 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.